Radiation therapy for lung cancer causes a predictable set of side effects, most of which develop gradually during treatment and resolve within weeks to months afterward. The most common are fatigue, difficulty swallowing, cough, shortness of breath, and skin irritation in the treatment area. Some side effects, like lung inflammation, can appear weeks after treatment ends and may require medical attention. What you experience depends on the type of radiation, the dose, and whether you’re also receiving chemotherapy.
The Most Common Early Side Effects
Side effects from chest radiation tend to build up over the course of treatment rather than hitting all at once. Fatigue is nearly universal and often the most disruptive to daily life. It’s not the kind of tiredness that a good night’s sleep fixes. It’s a deeper, persistent exhaustion that can make routine activities feel like a significant effort. Light physical activity, even short walks, can help counteract this fatigue. Avoiding long naps during the day and keeping a consistent sleep routine also make a difference.
Cough and shortness of breath are common as well. Radiation irritates the airways and lung tissue in and around the treatment area, which can make breathing feel more effortful than usual. If you already have reduced lung function from the cancer itself or from smoking history, these symptoms can feel more pronounced. A dry, persistent cough affects roughly 40 to 50% of patients during treatment.
Hair loss only occurs in the area being treated, so chest radiation may thin or remove hair on the chest but won’t affect your head. Fatigue and breathing symptoms typically peak toward the end of the treatment course and in the first few weeks after it wraps up, then gradually improve.
Swallowing Problems and Esophagitis
One of the more significant side effects is inflammation of the esophagus, the tube connecting your throat to your stomach. The esophagus runs right through the chest, so it often sits in or near the radiation field. About 48% of patients develop moderate or worse esophagitis during treatment. It typically feels like a sore throat that extends into the chest, making swallowing painful or difficult. Some people describe it as food getting stuck or a burning sensation behind the breastbone.
In most cases, the inflammation is manageable with soft foods, smaller meals, and pain relief. Severe esophagitis, the kind that might require a feeding tube or hospitalization, occurs in roughly 2 to 7% of patients receiving standard doses. Several factors raise your risk: lower body weight, older age, more advanced lymph node involvement, and already having some difficulty swallowing before treatment starts. If you’re receiving chemotherapy at the same time (more on that below), the risk of severe esophagitis climbs further, reaching up to 18% in some treatment regimens.
Skin Reactions in the Treatment Area
The skin over your chest where the radiation beam enters and exits will likely become irritated. It often starts as mild redness and dryness, similar to a sunburn. For some people, this progresses to peeling or, in more advanced cases, moist patches where the top layer of skin breaks down. About 30 to 35% of patients experience some degree of skin reaction.
Gentle care makes a real difference. Wash the area with mild, unscented soap and lukewarm water, using your hands rather than a washcloth. Pat dry instead of rubbing. Your treatment team will recommend specific unscented moisturizers that don’t contain lanolin. Avoid applying anything to the area, including over-the-counter creams, without checking first, since some products can interfere with treatment or worsen irritation.
If you need to cover the area with bandages, use paper tape placed away from the treatment zone and reposition it each time so you’re not repeatedly pulling on the same skin. Contact your care team if the skin becomes warm to the touch, develops unusual discoloration, starts draining foul-smelling liquid, or if you develop a fever above 100.4°F. These are signs of infection that need prompt attention.
Radiation Pneumonitis: A Delayed Concern
Radiation pneumonitis is inflammation of the lung tissue itself, and it’s one of the side effects that catches people off guard because it typically shows up one to three months after treatment ends, not during it. Symptoms include a new or worsening cough, shortness of breath, and sometimes a low-grade fever. It can feel like a chest cold that won’t resolve.
Rates vary depending on the treatment approach. In a randomized trial comparing stereotactic body radiation (SBRT) to conventional radiation for early-stage lung cancer, pneumonitis of any grade occurred in 19% of SBRT patients and 34% of those receiving conventional radiation. Most cases are mild and resolve on their own or with a short course of anti-inflammatory medication. Severe pneumonitis is less common but can lead to permanent scarring of lung tissue, called fibrosis, which may cause lasting changes in breathing capacity.
How SBRT Differs From Conventional Radiation
Not all radiation therapy is the same, and the type you receive affects which side effects are most likely. Conventional radiation delivers smaller doses over many sessions, typically five days a week for several weeks. SBRT delivers much higher doses per session over just three to five treatments, targeting the tumor with extreme precision.
SBRT generally causes fewer side effects overall because less surrounding tissue is exposed. In one head-to-head trial, esophagitis occurred in only 8% of SBRT patients compared to 30% with conventional radiation. Pneumonitis rates were also lower with SBRT (19% vs. 34%), and cough and breathing difficulties trended lower as well. The one exception: rib fractures. Because SBRT delivers concentrated doses, ribs near the treatment area are slightly more vulnerable. About 17% of SBRT patients in the trial experienced some degree of rib fracture, compared to 11% with conventional radiation, though most were mild.
SBRT is typically used for early-stage tumors that are relatively small and not near central airways. Larger or more advanced cancers usually require conventional radiation, sometimes combined with chemotherapy.
When Chemotherapy Is Given at the Same Time
For locally advanced lung cancer, radiation is often given alongside chemotherapy, a combination called chemoradiation. This improves the cancer-fighting effect but also amplifies side effects. The toxicity profile shifts in important ways.
Esophagitis becomes both more frequent and more severe. Severe swallowing problems (grade 3 or higher) occur in up to 18% of patients on concurrent chemoradiation, compared to the roughly 2% seen with radiation alone. Certain chemotherapy combinations, particularly those built around high-dose cisplatin, also bring nausea, vomiting, and drops in blood cell counts that radiation alone wouldn’t cause. Lower-dose chemotherapy schedules tend to produce a more tolerable side effect profile while still boosting the effectiveness of radiation.
Fatigue tends to be deeper and longer-lasting with the combination. If you’re facing chemoradiation, your team will monitor your blood counts and nutritional status more closely throughout treatment.
Lung Fibrosis and Other Long-Term Effects
Some side effects don’t fully resolve after treatment. Lung fibrosis, where radiation-damaged tissue is replaced by scar tissue, develops in roughly 40 to 50% of patients to some degree. In most cases it’s mild and shows up on imaging without causing noticeable symptoms. When it does affect breathing, it tends to manifest as a permanent, modest reduction in lung capacity. Staying physically active after treatment helps maintain the lung function you have.
Dyspnea, or shortness of breath, is one of the most persistent symptoms. In clinical trials, moderate to severe breathing difficulty affected about 27% of SBRT patients and 39% of conventional radiation patients. For people who already had compromised lung function before treatment, this can have a meaningful impact on daily activities like climbing stairs or walking longer distances.
Rib fractures, though uncommon, can cause lingering chest wall pain. And while rare, radiation to the chest carries a small long-term risk of damage to the heart, particularly when the tumor is located in the left lung or near the center of the chest. Modern treatment planning techniques aim to minimize heart exposure, but it remains a consideration your radiation oncologist will factor into your plan.